Skip to main content

Table 1 Clinicopathological characteristics of pancreatic cancer patients

From: RETRACTED ARTICLE: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer

Parameter

 

eEF1A2 protein

miR-663

  

Expression level

P value

Expression level

P value

Gender

     

  Male

45

0.706 ± 0.1486

0.230

0.421 ± 0.2493

0.426

  Female

23

0.750 ± 0.1272

 

0.374 ± 0.1669

 

Age (years)

     

  <60

42

0.702 ± 0.1515

0.163

0.422 ± 0.2552

0.436

  ≥60

26

0.751 ± 0.1227

 

0.378 ± 0.1649

 

Diameter (cm)

     

  <3

51

0.715 ± 0.1471

0.566

0.425 ± 0.2322

0.218

  ≥3

17

0.738 ± 0.1294

 

0.347 ± 0.1947

 

Location

     

  Head

48

0.713 ± 0.1394

0.486

0.398 ± 0.2057

0.663

  Body, tail

20

0.739 ± 0.1511

 

0.423 ± 0.2696

 

Differentiation

     

  Well

13

0.643 ± 0.1667

 

0.518 ± 0.3358

 

  Moderate

39

0.735 ± 0.1265

0.086

0.383 ± 0.1812

0.124

  Poor

16

0.747 ± 0.1453

 

0.366 ± 0.1947

 

TNM stage

     

  I-II

30

0.670 ± 0.1635

0.009*

0.498 ± 0.2742

0.004*

  III-IV

38

0.760 ± 0.1098

 

0.332 ± 0.1411

 

Nodal status

     

  Negative

36

0.688 ± 0.1632

0.048*

0.464 ± 0.2623

0.017*

  Positive

32

0.757 ± 0.1057

 

0.338 ± 0.1505

 
  1. *Indicated statistical significance (P < 0.05).